Arginine News and Research

RSS
Arginine is considered a semi-essential amino acid because even though the body normally makes enough of it, supplementation is sometimes needed. For example, people with protein malnutrition, excessive ammonia production, excessive lysine intake, burns, infections, peritoneal dialysis, rapid growth, urea synthesis disorders, or sepsis may not have enough arginine. Symptoms of arginine deficiency include poor wound healing, hair loss, skin rash, constipation, and fatty liver.

Arginine changes into nitric oxide, which causes blood vessel relaxation (vasodilation). Early evidence suggests that arginine may help treat medical conditions that improve with vasodilation, such as chest pain, clogged arteries (called atherosclerosis), coronary artery disease, erectile dysfunction, heart failure, intermittent claudication/peripheral vascular disease, and blood vessel swelling that causes headaches (vascular headaches). Arginine also triggers the body to make protein and has been studied for wound healing, bodybuilding, enhancement of sperm production (spermatogenesis), and prevention of wasting in people with critical illnesses.

Arginine hydrochloride has a high chloride content and has been used to treat metabolic alkalosis. This use should be under the supervision of a qualified healthcare professional.
Researchers find kidney-specific gene defects may increase risk of heart failure

Researchers find kidney-specific gene defects may increase risk of heart failure

Scientists introduce DNA directly into cell nucleus using protein nanodisks

Scientists introduce DNA directly into cell nucleus using protein nanodisks

Aeterna Zentaris reaches agreement with FDA for Solorel SPA as a diagnostic test in AGHD

Aeterna Zentaris reaches agreement with FDA for Solorel SPA as a diagnostic test in AGHD

Scientist suggests functional amino acids play a critical role in human health

Scientist suggests functional amino acids play a critical role in human health

UC Davis researchers identify new pathway to repair oxidative-damaged DNA

UC Davis researchers identify new pathway to repair oxidative-damaged DNA

Gilead announces results from Phase III clinical trial of Cayston, TIS in cystic fibrosis patients

Gilead announces results from Phase III clinical trial of Cayston, TIS in cystic fibrosis patients

Watermelon effective against prehypertension

Watermelon effective against prehypertension

Some herbal remedies for anxiety disorders effective

Some herbal remedies for anxiety disorders effective

Herbal supplements can treat anxiety disorders

Herbal supplements can treat anxiety disorders

Aeterna Zentaris' AEZS-130 demonstrates potential as oral diagnostic test for AGHD

Aeterna Zentaris' AEZS-130 demonstrates potential as oral diagnostic test for AGHD

Cardium expands wound healing and tissue regeneration portfolio

Cardium expands wound healing and tissue regeneration portfolio

Researchers report massage improves body’s immune response

Researchers report massage improves body’s immune response

Amino acid arginine vital in fighting infection

Amino acid arginine vital in fighting infection

David Mosser to discuss primary duty of macrophages at American Physiological Society conference

David Mosser to discuss primary duty of macrophages at American Physiological Society conference

Dietary supplement to boost nitric oxide increases stamina during high intensity exercise: Research

Dietary supplement to boost nitric oxide increases stamina during high intensity exercise: Research

ForeverGreen reports decrease in revenue for second quarter 2010

ForeverGreen reports decrease in revenue for second quarter 2010

Cluster-coated implant strengthens attachment of joint-replacement implant with bone

Cluster-coated implant strengthens attachment of joint-replacement implant with bone

Mutation in ion channel that changes its dynamics is implicated in epilepsy: Scientists

Mutation in ion channel that changes its dynamics is implicated in epilepsy: Scientists

Phase III clinical trial data of Cayston versus TIS in CF patients with P. aeruginosa presented at ECFC 2010

Phase III clinical trial data of Cayston versus TIS in CF patients with P. aeruginosa presented at ECFC 2010

Polaris' ADI-PEG 20 novel anticancer drug inhibits growth of metastatic melanoma cells: Study

Polaris' ADI-PEG 20 novel anticancer drug inhibits growth of metastatic melanoma cells: Study